The genetics of prostate cancer risk
Saturday, July 3rd, 2010 Posted in Uncategorized | 6 Comments »According to an article in today’s (29 June) Wall Street Journal, scientists may soon be able to answer the agonizing question facing men with prostate cancer whether a specific individual actually needs early and aggressive treatment for his cancer or can simply ...
Watchful Waiting often best strategy for slow-progressing prostate cancer
Monday, June 21st, 2010 Posted in Uncategorized | No Comments »According to a large-scale study from Sweden, for patients with prostate cancer that has a low risk of development, watchful waiting, also known as "active surveillance," may be a suitable treatment option, . The issue of how (or whether) to treat ...
What prostate treatment is best for quality of life?
Tuesday, April 6th, 2010 Posted in Uncategorized | 2 Comments »According to a new study, despite the popularity of robot-assisted procedures for prostate cancer, when it comes to men's long-term quality of life, patients with earlier stage cancers generally fare better with non-surgical approaches than with surgery. Prostate patients with earlier ...
PSA test reduces prostate cancer deaths by 40%
Saturday, March 13th, 2010 Posted in Uncategorized | No Comments »According to Skip Lockwood, CEO of ZERO – The Project to End Prostate Cancer, The American Cancer Society is a 'false prophet' when it comes to telling the truth about the effectiveness of the PSA test." Dr. William J. Catalona of ...
Research suggest therapy choice is influenced by physicians’ preferences
Tuesday, March 9th, 2010 Posted in Uncategorized | No Comments »New research shows that the kind of treatment received by prostate cancer patients often depends on the type of specialist providing the patient's care. U.S. researchers evaluated data on more than 85,000 Medicare beneficiaries aged 65 and olde. All of them ...
New evaluation of patients eligible for active surveillance protocols
Tuesday, January 12th, 2010 Posted in Uncategorized | No Comments »A recent study at CHU Henri Mondor, Créteil, France, has compared the pathological findings and prostate specific antigen outcome after radical prostatectomy in men eligible for active surveillance according to 3 biopsy inclusion criteria. The team has added to the data ...
Proliferation of minimally invasive surgery vs open radical prostatectomy
Thursday, January 7th, 2010 Posted in Uncategorized | No Comments »Over the past seven to eight years there has been noted a proliferation of minimally invasive surgery (MIS) techniques for the treatment of urologic malignancies. This evolution is no better demonstrated than the radical prostatectomy surgery</a for patients with prostate ...
Criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer
Tuesday, December 15th, 2009 Posted in Uncategorized | No Comments »A recent study at Vita-Salute University San Raffaele, Milan, Italy. aimed to test the ability of two of the most stringent criteria used to identify patients with low-risk prostate cancer suitable for active surveillance (AS) to correctly exclude patients with ...
Experimental prostate cancer drugs tested in Belfast
Thursday, November 19th, 2009 Posted in Uncategorized | No Comments »Around 10,000 men in the UK die from prostate cancer each year. This is one of the reason Belfast City Hospital joins other leading research hospitals around the world in using the experimental drugs designed to help men whose cancer ...
Concerns related to robotic prostate cancer surgery
Friday, October 16th, 2009 Posted in Uncategorized | No Comments »A recent national study, which appeared in Wednesday's Journal of the American Medical Association, is raising some concerns about robotic prostate cancer surgery, a procedure widely used by local hospitals and promoted as having fewer complications than traditional prostate surgery. The ...